fda glp-1 warning letters october 2025 news National Hispanic Medical Association | After compounded drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and Why the FDA Issued 30

Lower tolerance : Many patients report feeling intoxicated from smaller amounts than before treatment

Es una hiptesis atractiva, pero desafortunadamente la evidencia cientfica en que se apoya es muy dbil o no existe

The article contrasts berberine studies of roughly 30 to 100 participants followed for eight to sixteen weeks with GLP-1 agonist trials involving thousands of patients followed for one to three years

While both drugs reported similar gastrointestinal side effects, Zepbound showed a lower discontinuation rate ( 6.1% vs

Laboratory studies demonstrate that while the compound remains stable at room temperature for weeks, refrigeration significantly minimizes degradation and extends usable research timeframes

The authors thank Novo Nordisk for provision of semaglutide for the study